.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
QuintilesIMS
Chinese Patent Office
AstraZeneca
Teva
Baxter
Federal Trade Commission
Medtronic
Mallinckrodt
Healthtrust

Generated: July 21, 2017

DrugPatentWatch Database Preview

INSULATARD NPH HUMAN Drug Profile

« Back to Dashboard

What is the patent landscape for Insulatard Nph Human, and what generic Insulatard Nph Human alternatives are available?

Insulatard Nph Human is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in INSULATARD NPH HUMAN is insulin susp isophane semisynthetic purified human. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin susp isophane semisynthetic purified human profile page.

Summary for Tradename: INSULATARD NPH HUMAN

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list7,676
Drug Prices:see details
DailyMed Link:INSULATARD NPH HUMAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
INSULATARD NPH HUMAN
insulin susp isophane semisynthetic purified human
INJECTABLE;INJECTION019449-001May 30, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Department of Justice
Fuji
Fish and Richardson
Cipla
Novartis
Accenture
UBS
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot